Government agencies and non-profits at Cell 2026
Nov 12–13, 2026 London, UK ~800 attendees Website
7 government agencies and non-profits are at Cell 2026 — 17 presentations on the program. Most represented: Cell and Gene Therapy Catapult (4 on the program), NHS (2 on the program), EMEUNET (1 on the program). 5 of them have their own page in this guide. As of Oct 8, 2026.
Topic
Top represented
Showing 1–7 of 7 organizations
| Organization | Cell 2026 Attendance |
|---|---|
Cell and Gene Therapy Catapult London, UK | |
UK innovation centre helping cell and gene therapy developers with process development, GMP manufacturing space and regulatory support. | Talk Thu Nov 12 3:05pm–3:30pm Enabling Affordable Gene Therapies Through Continuous Viral Vector Manufacturing Cell and gene therapyManufacturing and CMC Talk Thu Nov 12 5:45pm–6:10pm Talk Fri Nov 13 9:25am–9:50am rAAV Production Process Intensification Using Perfusion Bioreactor Technology Cell and gene therapyCell culture and upstream processing Talk Fri Nov 13 1:55pm–2:20pm Regulatory Initiatives For ATMPs In The UK Cell and gene therapy Panel Fri Nov 13 4:40pm–5:05pm |
The UK's publicly funded health service, whose hospitals run clinical trials and deliver approved cell and gene therapies. | Panel Thu Nov 12 5:45pm–6:10pm Solving the Capacity Crunch: How Do We Scale Advanced Therapy Operations Without Compromising Quality? Cell and gene therapyManufacturing and CMC Panel Fri Nov 13 2:45pm–3:10pm From Approval To Access: Why Cell & Gene Therapies Still Don’t Reach Patients Cell and gene therapy Talk Fri Nov 13 3:50pm–4:15pm CAR-T Clinical Trials In Hospitals Cell and gene therapy Talk Fri Nov 13 4:40pm–5:05pm Patient Access In Hospitals To Administer Cell & Gene Therapies Cell and gene therapy |
Network of early-career rheumatologists and researchers within EULAR, the European Alliance of Associations for Rheumatology. | Talk Fri Nov 13 1:55pm–2:20pm The Academic Model Of Advanced Therapies From A Clinician’s Point Of View Cell and gene therapy Panel Fri Nov 13 2:45pm–3:10pm From Approval To Access: Why Cell & Gene Therapies Still Don’t Reach Patients Cell and gene therapy |
NHS body supplying blood, organs, tissues and stem cells in England, with cell, apheresis and gene therapy services. | Talk Fri Nov 13 12:05pm–12:30pm Delivering Cell Therapies Into The NHS Cell and gene therapy Panel Fri Nov 13 4:40pm–5:05pm Navigating The Regulatory Lifecycle Of Advanced Therapies: From Platform Approval To Manufacturing & Post-Market Evidence Cell and gene therapyManufacturing and CMC |
Novo Nordisk Foundation Cellerator Lyngby, Denmark | |
Foundation-funded initiative that helps move stem cell-based therapies from lab research into clinical manufacturing. | Talk Fri Nov 13 11:40am–12:05pm Why Regenerative Medicine Stalls And How Europe Can Fix It Cell and gene therapy Panel Fri Nov 13 2:45pm–3:10pm From Discovery To Deliverability: Building The Next Generation Of Cell Therapies Cell and gene therapy |
Trade association representing research-based pharmaceutical companies in the UK. | Talk Fri Nov 13 2:45pm–3:10pm The UK As An Attractive Destination For Cell & Gene Therapy Research Cell and gene therapy |
M MHRA London, UK | |
UK regulator of medicines, medical devices and blood products, which also sets biological reference standards. | Talk Fri Nov 13 5:30pm–5:55pm Development Of A WHO Approved Phenotypic Flow Standard For Mesenchymal Stromal Cells Analytics and characterizationStem cells, organoids and cell models |
Instantly find 20 buyers from government agencies and non-profits
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse Cell 2026 by
Organization type
Topic
Everyone
Not affiliated with or endorsed by Cell 2026 or its organizers. Submit a correction